|71.75||-1.08||-1.48%||Vol 300.21K||1Y Perf 227.46%|
|Apr 9th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||81.25||Analyst Rating||Strong Buy 1.00|
|Potential %||13.24||Finscreener Ranking||★★★★ 54.12|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★ 47.41|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 58.01|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||3.72B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||64.53||Earnings Date||29th Apr 2021|
Today's Price Range
5 Year PE Ratio Range
|5 Years||1 301.37%|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||29th Apr 2021|
|Estimated EPS Next Report||-0.14|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||391.69K|
|Avg. Monthly Volume||686.00K|
|Avg. Quarterly Volume||810.44K|
CareDx Inc. (NASDAQ: CDNA) stock closed at 71.75 per share at the end of the most recent trading day (a -1.48% change compared to the prior day closing price) with a volume of 316.31K shares and market capitalization of 3.72B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 475 people. CareDx Inc. CEO is Reginald Seeto.
The one-year performance of CareDx Inc. stock is 227.46%, while year-to-date (YTD) performance is -0.97%. CDNA stock has a five-year performance of 1301.37%. Its 52-week range is between 20.67 and 99.83, which gives CDNA stock a 52-week price range ratio of 64.53%
CareDx Inc. currently has a PE ratio of -167.60, a price-to-book (PB) ratio of 12.71, a price-to-sale (PS) ratio of 23.72, a price to cashflow ratio of 94.70, a PEG ratio of 2.32, a ROA of -7.01%, a ROC of -9.91% and a ROE of -9.71%. The company’s profit margin is -8.19%, its EBITDA margin is -10.30%, and its revenue ttm is $153.81 Million , which makes it $2.97 revenue per share.
Of the last four earnings reports from CareDx Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.14 for the next earnings report. CareDx Inc.’s next earnings report date is 29th Apr 2021.
The consensus rating of Wall Street analysts for CareDx Inc. is Strong Buy (1), with a target price of $81.25, which is +13.24% compared to the current price. The earnings rating for CareDx Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CareDx Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
CareDx Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 18.75, ATR14 : 7.48, CCI20 : -138.44, Chaikin Money Flow : -0.11, MACD : -4.78, Money Flow Index : 42.21, ROC : -19.53, RSI : 37.12, STOCH (14,3) : 25.09, STOCH RSI : 0.33, UO : 41.73, Williams %R : -74.91), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CareDx Inc. in the last 12-months were: Fred E. Cohen (Option Excercise at a value of $306 005), George W. Bickerstaff (Sold 30 000 shares of value $1 270 560 ), Michael Brian Bell (Option Excercise at a value of $664 737), Michael Brian Bell (Sold 89 710 shares of value $3 225 519 ), Michael D. Goldberg (Sold 50 000 shares of value $2 702 978 ), Peter Maag (Option Excercise at a value of $1 211 078), Peter Maag (Sold 539 600 shares of value $20 924 033 ), Ralph Snyderman (Sold 12 000 shares of value $1 066 513 ), Reginald Seeto (Sold 19 067 shares of value $1 483 501 ), Sasha King (Option Excercise at a value of $1 205 031), Sasha King (Sold 152 104 shares of value $7 539 278 ), William A. Hagstrom (Option Excercise at a value of $101 600), William A. Hagstrom (Sold 40 000 shares of value $1 419 545 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.